# Women in Dual With Dolutegravir

> **NCT05735535** · PHASE3 · UNKNOWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 290 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Antiviral Agents

## Key facts

- **NCT ID:** NCT05735535
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-09-15
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05735535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05735535, "Women in Dual With Dolutegravir". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05735535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*